摘要 |
<p>The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-digestive tract derived abdominal disorders associated with pain, in particular Interstitial Cystitis, Chronic Pelvic Pain Syndrome and/or abdominal pain associated with endometriosis.</p> |